FDA Inspection 1031217 — Michael Schenker, M.D.
The FDA completed an inspection of Michael Schenker, M.D. on October 12, 2017 in Craiova. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- October 12, 2017
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Craiova (Romania)
Additional Details
Clinical Investigator (CI)